Prescription drug · ANDA
Edaravone NDC 0781-3527
Edaravone 30 mg/100mL · Injection · Intravenous · Sandoz Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0781-3527-20 | 00781352720 | 2 BAG in 1 CARTON (0781-3527-20) / 100 mL in 1 BAG (0781-3527-94)Marketed from Jan 21, 2025 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Edaravone
- Generic name (nonproprietary)
- edaravone
- Active ingredients
- Edaravone — 30 mg/100mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- Sandoz IncNDC labeler code 0781
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 216902
- Marketing start
- Listing expires
- Identifiers
- Product ID 0781-3527_ae940bc6-1e6a-4b76-825c-bd2e1925e39aSPL ID ae940bc6-1e6a-4b76-825c-bd2e1925e39aSPL set ID ae940bc6-1e6a-4b76-825c-bd2e1925e39aRxCUI 1924316UNII S798V6YJRP
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400781352720followed by a unit qualifier and the quantityPackage 00781-3527-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Edaravone injection is indicated for the treatment of amyotrophic lateral sclerosis (ALS). Edaravone injection is indicated for the treatment of amyotrophic lateral sclerosis (ALS). ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0781-3527
- What is NDC 0781-3527?
- 0781-3527 is the product NDC for Edaravone, Edaravone 30 mg/100mL injection, listed with the FDA by Sandoz Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Edaravone.
- What is the active ingredient?
- Edaravone.
- Who is the labeler?
- Sandoz Inc, NDC labeler code 0781. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Edaravone?
- 3 other product NDCs are listed under this name. See all Edaravone NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Edaravone products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Edaravone | Edaravone 30 mg/100mL | Injection, SolutionIntravenous | Piramal Critical Care Inc. | 66794-259 | 66794-0259-64 |
| edaravone | Edaravone 30 mg/100mL | Injection, SolutionIntravenous | Gland Pharma Limited | 68083-500 | 68083-0500-02 |
| edaravone | Edaravone 60 mg/100mL | Injection, SolutionIntravenous | Gland Pharma Limited | 68083-501 | 68083-0501-01 |